CLASS III Drug recall · Reported 13 Apr 2016 · FDA Enforcement Report

Sodium Iodide I, USP Diagnostic Oral recalled by Jubilant Draximage

Jubilant Draximage is recalling Sodium Iodide I, USP Diagnostic Oral, distributed nationwide in the US. The recall was initiated on 11 Mar 2016 and the FDA has classified it as Class III.

Check your package

Lot, batch or date codesLot Number 1670123; Exp 04/16
NDC65174-461
Quantity recalled90 vials (450 capsules)

Check the lot number on your package against the affected lots. If it matches, contact the pharmacy that dispensed it or your prescriber before stopping any medication.

Recall details

Recall number
D-0812-2016
FDA event ID
73586
Recalling firm
Jubilant Draximage, Kirkland, N/A
Manufacturer
Jubilant DraxImage Inc., dba Jubilant Radiopharma
Classification
Class III
Status
Terminated
Recall initiated
11 Mar 2016
FDA classified
6 Apr 2016
Reported
13 Apr 2016
Type
Voluntary: Firm initiated
Customers notified by
E-Mail
Reason category
Other Reasons

Timeline

11 Mar 2016Recall initiated by company
6 Apr 2016Classified by FDA+26 days
13 Apr 2016Published in enforcement report+7 days

Companies usually start a recall weeks before the FDA classifies and publishes it; the gap above is that lag.

Reason for recall

Labeling: Label Error on Declared Strength

Product as listed by the FDA

SODIUM IODIDE I 131 CAPSULE, USP DIAGNOSTIC ORAL , Rx only, Manufactured by Jubilant DraxImage, Inc., Kirkland, QC, Canada, NDC 65174-461-05

Where it was distributed

Nationwide

Nationwide

Stores named: Costco

Questions about this recall

Why was it recalled?

Labeling: Label Error on Declared Strength

Which lots are affected?

Lot Number 1670123; Exp 04/16

Where was it sold?

Nationwide

What should I do if I have it?

Check the lot number on your package against the affected lots. If it matches, contact the pharmacy that dispensed it or your prescriber before stopping any medication.

What does Class III mean?

Class III recalls are for products unlikely to cause any adverse health consequence, usually labelling or quality issues.

Read the official FDA notice · Source record retrieved 26 Sep 2026. The FDA describes openFDA data as unvalidated; the official notice takes precedence. This page reports the record and gives no medical advice.

More recalls from Jubilant Draximage

All 3

Other Sodium Iodide I 131 recalls

All 3
ReportedClassRecallCompanyReasonWhere
DrugCLASS IIIGelatin Capsule Pack for use recalled by RadnostixSodium Iodide I-131RadnostixPackaging DefectsNationwide
DrugCLASS IISodium Iodide (I-131) Solution, Therapeutic Oral recalled by RadnostixSodium Iodide I-131RadnostixParticulate MatterNationwide